IMM 3.45% 30.0¢ immutep limited

see what happened to tis today, page-56

  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    poie 100

    It seems you have drawn your broad conclusions from some very perfunctory research of O.C., the market and the treatment methodology that Cvac provides.

    If you are genuinely interested in educating yourself more on these subjects, the most comprehensive source of information is the RM Research report on PRR, issued in January of this year.

    You can download a copy at:

    http://www.primabiomed.com.au/investor/analyst_reports_pdf/RM-Research-Prima-Biomed-Ltd-29-January-2013.pdf

    Settle in for a long read!
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.